Shopping Cart 0
Cart Subtotal
USD 0

Cardiopulmonary Bypass Equipment - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiopulmonary Bypass Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiopulmonary Bypass Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiopulmonary Bypass Equipment under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Cardiopulmonary Bypass Equipment Overview 5

3 Products under Development 6

3.1 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

3.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

3.3 Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

3.4 Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9

4 Cardiopulmonary Bypass Equipment-Pipeline Products under Development by Companies 10

4.1 Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 10

4.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 11

5 Cardiopulmonary Bypass Equipment Companies and Product Overview 12

5.1 AngioDynamics Inc Company Overview 12

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 Circulatory Technology Inc. Company Overview 14

5.2.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 Design Mentor, Inc. Company Overview 15

5.3.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.4 LivaNova PLC Company Overview 16

5.4.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.5 Monash University Company Overview 17

5.5.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 17

5.6 Nikkiso Co Ltd Company Overview 18

5.6.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.7 Nipro Corp Company Overview 19

5.7.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 19

5.8 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 20

5.8.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

5.9 University of Pittsburgh Company Overview 21

5.9.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 21

5.10 University of Strathclyde Company Overview 22

5.10.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 22

6 Cardiopulmonary Bypass Equipment- Recent Developments 23

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 23

6.2 May 15, 2018: Getinge announces its commitment to EuroPCR 25

6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 25

6.4 May 07, 2018: Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems Due to Revised Cleaning Instructions 26

6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 27

6.6 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 27

6.7 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 29

6.8 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 30

6.9 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 31

6.10 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 33

6.11 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 33

6.12 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 34

6.13 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 36

6.14 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 36

6.15 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 38

6.16 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development 39

6.17 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 40

6.18 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 41

6.19 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 42

6.20 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 42

6.21 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 44

6.22 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 47

6.23 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 48

6.24 Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 48

6.25 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 50

6.26 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 51

6.27 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52

6.28 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 53

6.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 53

6.30 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 54

6.31 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 55

6.32 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 56

6.33 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 57

6.34 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 58

6.35 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 60

6.36 Aug 08, 2017: Biological bypass shows promise in coronary artery disease 62

6.37 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 62

6.38 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 64

6.39 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 66

6.40 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 67

7 Appendix 68

7.1 Methodology 68

7.2 About GlobalData 71

7.3 Contact Us 71

7.4 Disclaimer 71


List Of Figure

1.2 List of Figures

Figure 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

Figure 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

Figure 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

Figure 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9


List Of Table

1.1 List of Tables

Table 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

Table 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

Table 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

Table 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9

Table 5: Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 10

Table 6: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 11

Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: AngioVac Line Extension-Product Status 12

Table 9: AngioVac Line Extension-Product Description 13

Table 10: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 11: Heart Lung Machine-Product Status 14

Table 12: Heart Lung Machine-Product Description 14

Table 13: Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 14: VentriFlo Pump-Product Status 15

Table 15: VentriFlo Pump-Product Description 15

Table 16: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 17: LBATS-Product Status 16

Table 18: LBATS-Product Description 16

Table 19: Monash University Pipeline Products & Ongoing Clinical Trials Overview 17

Table 20: Cardio By-Pass Machine-Product Status 17

Table 21: Cardio By-Pass Machine-Product Description 17

Table 22: Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 23: Cardiopulmonary Bypass Pump-Product Status 18

Table 24: Cardiopulmonary Bypass Pump-Product Description 18

Table 25: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 26: Venous And Arterial Cannula-Product Status 19

Table 27: Venous And Arterial Cannula-Product Description 19

Table 28: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

Table 29: Paediatric And Neonatal Arterial Filter-Product Status 20

Table 30: Paediatric And Neonatal Arterial Filter-Product Description 20

Table 31: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 21

Table 32: Portable Emergency Cardiopulmonary Bypass Device-Product Status 21

Table 33: Portable Emergency Cardiopulmonary Bypass Device-Product Description 21

Table 34: University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 22

Table 35: Neonatal Life Support System-Product Status 22

Table 36: Neonatal Life Support System-Product Description 22

Table 37: Glossary 70

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

AngioDynamics Inc, AngioVac Line Extension; Circulatory Technology Inc., Heart Lung Machine; Design Mentor, Inc., VentriFlo Pump; LivaNova PLC , LBATS; Monash University, Cardio By-Pass Machine; Nikkiso Co Ltd, Cardiopulmonary Bypass Pump; Nipro Corp, Venous And Arterial Cannula; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Paediatric And Neonatal Arterial Filter; University of Pittsburgh, Portable Emergency Cardiopulmonary Bypass Device; University of Strathclyde, Neonatal Life Support System


Companies

AngioDynamics Inc

Circulatory Technology Inc.

Design Mentor, Inc.

LivaNova PLC

Monash University

Nikkiso Co Ltd

Nipro Corp

Sree Chitra Tirunal Institute for Medical Sciences & Technology

University of Pittsburgh

University of Strathclyde

Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiopulmonary Bypass Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiopulmonary Bypass Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiopulmonary Bypass Equipment under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Cardiopulmonary Bypass Equipment Overview 5

3 Products under Development 6

3.1 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

3.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

3.3 Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

3.4 Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9

4 Cardiopulmonary Bypass Equipment-Pipeline Products under Development by Companies 10

4.1 Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 10

4.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 11

5 Cardiopulmonary Bypass Equipment Companies and Product Overview 12

5.1 AngioDynamics Inc Company Overview 12

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 Circulatory Technology Inc. Company Overview 14

5.2.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 Design Mentor, Inc. Company Overview 15

5.3.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.4 LivaNova PLC Company Overview 16

5.4.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.5 Monash University Company Overview 17

5.5.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 17

5.6 Nikkiso Co Ltd Company Overview 18

5.6.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.7 Nipro Corp Company Overview 19

5.7.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 19

5.8 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 20

5.8.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

5.9 University of Pittsburgh Company Overview 21

5.9.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 21

5.10 University of Strathclyde Company Overview 22

5.10.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 22

6 Cardiopulmonary Bypass Equipment- Recent Developments 23

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 23

6.2 May 15, 2018: Getinge announces its commitment to EuroPCR 25

6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 25

6.4 May 07, 2018: Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems Due to Revised Cleaning Instructions 26

6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 27

6.6 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 27

6.7 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 29

6.8 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 30

6.9 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 31

6.10 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 33

6.11 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 33

6.12 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 34

6.13 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 36

6.14 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 36

6.15 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 38

6.16 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development 39

6.17 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 40

6.18 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 41

6.19 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 42

6.20 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 42

6.21 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 44

6.22 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 47

6.23 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 48

6.24 Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 48

6.25 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 50

6.26 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 51

6.27 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 52

6.28 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 53

6.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 53

6.30 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 54

6.31 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 55

6.32 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 56

6.33 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 57

6.34 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 58

6.35 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 60

6.36 Aug 08, 2017: Biological bypass shows promise in coronary artery disease 62

6.37 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 62

6.38 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 64

6.39 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 66

6.40 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 67

7 Appendix 68

7.1 Methodology 68

7.2 About GlobalData 71

7.3 Contact Us 71

7.4 Disclaimer 71


List Of Figure

1.2 List of Figures

Figure 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

Figure 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

Figure 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

Figure 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9


List Of Table

1.1 List of Tables

Table 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 6

Table 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 7

Table 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 8

Table 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 9

Table 5: Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 10

Table 6: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 11

Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: AngioVac Line Extension-Product Status 12

Table 9: AngioVac Line Extension-Product Description 13

Table 10: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 11: Heart Lung Machine-Product Status 14

Table 12: Heart Lung Machine-Product Description 14

Table 13: Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 14: VentriFlo Pump-Product Status 15

Table 15: VentriFlo Pump-Product Description 15

Table 16: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 17: LBATS-Product Status 16

Table 18: LBATS-Product Description 16

Table 19: Monash University Pipeline Products & Ongoing Clinical Trials Overview 17

Table 20: Cardio By-Pass Machine-Product Status 17

Table 21: Cardio By-Pass Machine-Product Description 17

Table 22: Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

Table 23: Cardiopulmonary Bypass Pump-Product Status 18

Table 24: Cardiopulmonary Bypass Pump-Product Description 18

Table 25: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 26: Venous And Arterial Cannula-Product Status 19

Table 27: Venous And Arterial Cannula-Product Description 19

Table 28: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 20

Table 29: Paediatric And Neonatal Arterial Filter-Product Status 20

Table 30: Paediatric And Neonatal Arterial Filter-Product Description 20

Table 31: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 21

Table 32: Portable Emergency Cardiopulmonary Bypass Device-Product Status 21

Table 33: Portable Emergency Cardiopulmonary Bypass Device-Product Description 21

Table 34: University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 22

Table 35: Neonatal Life Support System-Product Status 22

Table 36: Neonatal Life Support System-Product Description 22

Table 37: Glossary 70

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

AngioDynamics Inc, AngioVac Line Extension; Circulatory Technology Inc., Heart Lung Machine; Design Mentor, Inc., VentriFlo Pump; LivaNova PLC , LBATS; Monash University, Cardio By-Pass Machine; Nikkiso Co Ltd, Cardiopulmonary Bypass Pump; Nipro Corp, Venous And Arterial Cannula; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Paediatric And Neonatal Arterial Filter; University of Pittsburgh, Portable Emergency Cardiopulmonary Bypass Device; University of Strathclyde, Neonatal Life Support System


Companies

AngioDynamics Inc

Circulatory Technology Inc.

Design Mentor, Inc.

LivaNova PLC

Monash University

Nikkiso Co Ltd

Nipro Corp

Sree Chitra Tirunal Institute for Medical Sciences & Technology

University of Pittsburgh

University of Strathclyde